Constellium
CSTM
25.42
-0.08
-0.31%
Constellium
US · CSTM
#2400 by market cap
Listed 1970
25.42
-0.08
-0.31%
Live - 5344 symbols - heartbeat 298s ago
· 2026-10-08 07:00
Pre-market
25.40
-0.08%
After-hours
25.40
-0.08%
Overnight
25.40
-0.08%
- Market cap
- 3.45B
- P/E (TTM)i
- 6.57
- P/Bi
- 2.76
- EPSi
- 1.92
- Div yieldi
- 0.00%
- 52W posi
- 49%
Reader sentiment
Are you bullish or bearish on CSTM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.55, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.19% YoY
Margins
- Gross margin
- 14.05%
- Operating margin
- 5.61%
- Net margin
- 3.23%
Key ratios & quality
- Enterprise valuei
- 5.27B
- Altman Z-Scorei
- 2.55
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.50B | 5.47B | 6.01B | 6.97B | 8.53B | 7.83B | 7.34B | 8.45B |
| Gross profit | 615.42M | 548.88M | 602.68M | 751.79M | 963.00M | 1.06B | 938.00M | 1.19B |
| Selling & admin expenses | 282.54M | 265.48M | 291.50M | 292.11M | 284.00M | 317.00M | 313.00M | 332.00M |
| Research & development | 45.76M | 43.69M | 47.97M | 44.16M | 46.00M | 52.00M | 49.00M | 51.00M |
| Operating profit | 287.12M | 239.72M | 263.21M | 415.53M | 343.00M | 386.00M | 272.00M | 474.00M |
| Pretax profit | 253.95M | -38.09M | -41.82M | 358.91M | 150.00M | 232.00M | 135.00M | 408.00M |
| Tax | 36.60M | -19.04M | -20.91M | 62.27M | -165.00M | 75.00M | 75.00M | 133.00M |
| Net profit | 217.34M | -19.04M | -20.91M | 296.64M | 315.00M | 157.00M | 60.00M | 275.00M |
| Basic EPS | 2 | 0 | 0 | 2 | 2 | 1 | 0 | 2 |
| Diluted EPS | 1.57 | -0.17 | -0.18 | 1.98 | 2.14 | 1.04 | 0.38 | 1.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.98B | 2.10B | 2.17B | 2.20B | 2.46B | 2.75B |
| Gross profit | 263.00M | 263.00M | 314.00M | 347.00M | 420.00M | 480.00M |
| Selling & admin expenses | 75.00M | 84.00M | 85.00M | 81.00M | 94.00M | 97.00M |
| Research & development | 13.00M | 12.00M | 12.00M | 14.00M | 13.00M | 14.00M |
| Operating profit | 97.00M | 85.00M | 133.00M | 166.00M | 230.00M | 285.00M |
| Pretax profit | 62.00M | 56.00M | 126.00M | 164.00M | 272.00M | 214.00M |
| Tax | 24.00M | 20.00M | 38.00M | 51.00M | 76.00M | 66.00M |
| Net profit | 38.00M | 36.00M | 88.00M | 113.00M | 196.00M | 148.00M |
| Basic EPS | 0 | 0 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.26 | 0.25 | 0.62 | 0.79 | 1.47 | 1.04 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.65B | 1.51B | 1.80B | 2.19B | 2.22B | 1.99B | 1.83B | 2.32B |
| Cash & ST investments | 221.92M | 230.76M | 555.94M | 199.27M | 185.52M | 223.00M | 141.00M | 120.00M |
| Inventory | 754.98M | 750.52M | 715.83M | 1.19B | 1.42B | 1.20B | 1.18B | 1.41B |
| Total assets | 4.46B | 4.69B | 5.08B | 5.24B | 5.30B | 4.93B | 4.73B | 5.35B |
| Total current liabilities | 1.30B | 1.42B | 1.34B | 1.94B | 1.83B | 1.56B | 1.45B | 1.80B |
| Short-term debt | 65.20M | 225.15M | 113.16M | 292.11M | 158.71M | 59.00M | 39.00M | 39.00M |
| Long-term debt | 2.40B | 2.42B | 2.83B | 2.12B | 2.05B | 1.89B | 1.88B | 1.91B |
| Total liabilities | 4,592,770,533.06 | 4,782,014,517.43 | 5,202,696,054.31 | 4,905,912,456.69 | 4,492,273,375.59 | 4,191,000,000.00 | 4,007,000,000.00 | 4,383,000,000.00 |
| Total equity | -130.40M | -95.21M | -124.23M | 329.48M | 806.44M | 742.00M | 727.00M | 971.00M |
| Retained earnings | -623.43M | -581.37M | -661.71M | -168.70M | 330.30M | 201.00M | 93.00M | 354.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.24B | 2.31B | 2.35B | 2.32B | 2.95B | 3.27B |
| Cash & ST investments | 118.00M | 133.00M | 122.00M | 120.00M | 143.00M | 163.00M |
| Inventory | 1.28B | 1.33B | 1.37B | 1.41B | 1.67B | 1.88B |
| Total assets | 5.17B | 5.37B | 5.38B | 5.35B | 5.85B | 6.07B |
| Total current liabilities | 1.81B | 1.87B | 1.84B | 1.80B | 2.12B | 2.29B |
| Short-term debt | 54.00M | 75.00M | 59.00M | 39.00M | 35.00M | 42.00M |
| Long-term debt | 1.91B | 1.97B | 1.97B | 1.91B | 1.94B | 1.88B |
| Total liabilities | 4,403,000,000.00 | 4,569,000,000.00 | 4,512,000,000.00 | 4,383,000,000.00 | 4,713,000,000.00 | 4,816,000,000.00 |
| Total equity | 765.00M | 799.00M | 863.00M | 971.00M | 1.13B | 1.25B |
| Retained earnings | 116.00M | 152.00M | 240.00M | 354.00M | 529.00M | 673.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 75.50M | 500.72M | 410.80M | 404.20M | 365.00M | 432.00M | 301.00M | 489.00M |
| Depreciation & amortization | 225.35M | 286.76M | 318.56M | 302.30M | 290.00M | 300.00M | 304.00M | 330.00M |
| Free cash flow | -241.36M | 197.15M | 186.95M | 141.53M | 76.00M | 66.00M | -112.00M | 159.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | 0 | 0 | -79.00M | -115.00M |
| Ending cash balance | 187.60M | 206.11M | 539.95M | 166.44M | 176.00M | 223.00M | 141.00M | 120.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 58.00M | 114.00M | 99.00M | 218.00M | 73.00M | 161.00M |
| Depreciation & amortization | 78.00M | 82.00M | 84.00M | 86.00M | 83.00M | 84.00M |
| Free cash flow | -11.00M | 37.00M | 24.00M | 109.00M | 1.00M | 84.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -15.00M | -35.00M | -25.00M | -40.00M | -28.00M | -20.00M |
| Ending cash balance | 118.00M | 133.00M | 122.00M | 120.00M | 143.00M | 163.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | 344.80 | 59.00 | 16.11 | 6.84 | 32.93 |
| ROA %i | 4.82 | 1.44 | -0.53 | 5.64 | 6.13 | 2.64 | 1.13 | 5.41 |
| ROIC %i | -- | -- | -- | 14.68 | 14.60 | 7.27 | 4.87 | 12.44 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | 92.43 |
| EBIT margin %i | 6.26 | 3.93 | 2.11 | 7.18 | 3.87 | 4.30 | 3.24 | 6.08 |
| FCF / sales %i | -- | 2.98 | 3.11 | 2.03 | 2.19 | 2.33 | -- | 1.88 |
| Current ratioi | 1.27 | 1.06 | 1.35 | 1.13 | 1.22 | 1.28 | 1.27 | 1.29 |
| Quick ratioi | 0.68 | 0.53 | 0.78 | 0.50 | 0.41 | 0.48 | 0.43 | 0.47 |
| Debt / assetsi | 55.14 | 56.43 | 57.91 | 46.04 | 41.61 | 39.47 | 40.52 | 36.31 |
| LT debt / equityi | -- | -- | -- | 682.85 | 261.01 | 262.95 | 266.15 | 200.11 |
| Interest coveragei | 2.66 | 1.55 | 0.75 | 3.54 | 2.83 | 2.70 | 2.31 | 4.85 |
| Revenue CAGR (3Y) %i | 4.91 | 3.12 | -1.49 | 2.31 | 15.97 | 9.22 | 1.74 | -0.33 |
| Net income CAGR (3Y) %i | -- | -- | -- | 10.60 | -- | -- | -42.26 | -3.94 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -27.22 | -29.32 | -- | 27.90 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.44 | 3.55 | 12.21 | 32.93 | 46.67 | 53.80 |
| ROA %i | 1.40 | 0.60 | 2.11 | 5.41 | 7.90 | 9.53 |
| ROIC %i | 5.29 | 3.87 | 6.56 | 12.44 | 17.27 | 20.34 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.63 | 2.96 | 4.18 | 6.08 | 8.11 | 9.22 |
| FCF / sales %i | -- | -- | -- | 1.88 | 1.91 | 2.28 |
| Current ratioi | 1.24 | 1.23 | 1.28 | 1.29 | 1.39 | 1.43 |
| Quick ratioi | 0.52 | 0.50 | 0.51 | 0.47 | 0.54 | 0.58 |
| Debt / assetsi | 39.88 | 40.05 | 39.67 | 36.31 | 33.76 | 31.68 |
| LT debt / equityi | 269.40 | 266.03 | 245.33 | 200.11 | 173.19 | 150.96 |
| Interest coveragei | 2.62 | 2.12 | 3.11 | 4.85 | 6.83 | 8.25 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Packaging and Automotive Rolled Products (P&ARP) is the largest reported line at 61.14% of revenue, across 5 reported segments.
- Aerospace and Transportation (A&T) follows at 24.75%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Packaging and Automotive Rolled Products (P&ARP)61.14%
Aerospace and Transportation (A&T)24.75%
Automotive Structures and Industry (AS&I)16.67%
Quote time 2026-10-08 07:00:08 · For reference only, not investment advice and not tailored to your situation.